A Study Evaluating the Safety and Tolerability of a Seasonal Influenza Vaccine Containing LIQ001
Clinical trial NCT01224262 · COMPLETED
Trial details
- NCT number
- NCT01224262
- Sponsor
- Liquidia Technologies, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2011-12-01
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.